Compare Amphastar Pharmaceuticals Inc (AMPH) vs Micron Technology, Inc. (MU) Price & Performance

AMPH trades at $18.72, down 1.58% with bearish technical signals despite oversold RSI readings. The company reported mixed Q1 2026 results with EPS of $0.42 missing estimates of $0.70, continuing a trend of recent earnings disappointments. Valuation metrics appear reasonable with P/E of 11.29 and P/B of 1.07, while profitability remains solid with 47.34% gross margins. Recent news includes a Zacks Strong Sell rating and ongoing securities law investigation.

The stock faces near-term headwinds from earnings misses and negative analyst sentiment, though current valuations provide some downside protection. Upside potential exists if the company can execute its strategic pivot to proprietary drugs and biosimilars while managing BAQSIMI discount pressures. Key risks include ongoing legal scrutiny and competitive pressures in the generic drug market.

Micron Technology (MU) trades at $979.30, down 1.24% on the day, with strong technical support near $974 and bullish moving average signals. The company demonstrates exceptional fundamental strength with Q1 2026 EPS of $25.11 beating expectations by 20%, robust 55.91% net income margins, and accelerating revenue growth from $37.38B in 2025 to projected $90.3B in 2026. Recent news highlights the company's $250 billion AI memory investment and leadership in the semiconductor shortage cycle.

Outlook remains positive with 81% analyst buy ratings and $1,540 consensus price target representing 57% upside. Key opportunities include AI memory demand and humanoid robotics growth, while risks involve cyclical semiconductor exposure and competitive pressure from SK Hynix's Nasdaq debut. The stock presents a compelling growth story with strong earnings momentum and institutional support.